QIAGEN Launches New QIAcuity Digital PCR Kits And Updated Software To Expand Use By Biopharma And Food Safety Customers
Portfolio Pulse from Benzinga Newsdesk
QIAGEN (NYSE:QGEN) has announced the launch of three new kits for use on its QIAcuity systems and a major new software update. The new kits and software are designed to expand the use of digital PCR technology in areas such as cell and gene therapies, DNA and RNA quantification, and food and pharmaceutical safety. The company also plans to launch the QIAcuity Software 2.5 update in November, which will help researchers determine two key features of digital PCR analyses.
November 09, 2023 | 10:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
QIAGEN's launch of new kits and software for its QIAcuity systems could potentially increase its market share in the digital PCR technology sector.
The launch of new kits and software update could potentially increase QIAGEN's market share in the digital PCR technology sector. This is because the new products and software update are designed to expand the use of digital PCR technology in various sectors, which could attract more customers and increase sales.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100